We have all experienced a pandemic unique in the history of the world. Two elements, in particular, distinguished this pandemic from earlier global outbreaks. First, genetic technologies allowed scientists to almost instantly sequence the DNA of the novel coronavirus, once it was recognized as a unique infectious agent. That accelerated development of the vaccines.
Second was the global lockdown of ordinary citizens, accompanied by the ban on all public gatherings—be it sports, church services, concerts, or plays. Students did not go to school and parents worked from home. Cruise ships stayed in port, and the airlines carried just 25% of passengers per day compared to pre-pandemic levels.
Now, the latest stats on the Omicron variant indicate the pandemic may be winding down. On Jan. 24, 2022, the federal Centers for Disease Control and Prevention reported 1,025,249 new COVID-19 cases that day. As of Mar. 10, just 42,566 new COVID-19 cases were reported for that day.
These facts confront lab administrators and pathologists with the need to answer an important question: What happens to healthcare and the clinical laboratory industry as we move forward? Will the COVID-19 pandemic prove to be the fork in the road that propelled U.S. healthcare down a path that differed from what was laid out at the end of 2019?
Answer that question incorrectly and your laboratory organization may find itself moving in the wrong direction in coming years, with the consequence of lost clients and the inability to generate sufficient revenue to sustain operations. Answer the question correctly and the future could be clinically and financially robust for your laboratory, as well as for the hospitals, physicians, and payers and patients it serves.
As we’ve done for 27 years, your team at The Dark Report has been at work gathering experts who will share useful insights and knowledge about what’s coming next for healthcare and the House of Laboratory Medicine. When the Executive War College on Laboratory and Pathology Management convenes on April 27-28, 2022, in New Orleans, there will be 125 speakers and 75 sessions to help you understand what’s coming and how to position your lab to prosper. You should reserve your place today and bring your brightest management minds to this critical strategic gathering!
COVID-19: a Fork in the Road for Future Lab Testing?
We have all experienced a pandemic unique in the history of the world. Two elements, in particular, distinguished this pandemic from earlier global outbreaks. First, genetic technologies allowed scientists to almost instantly sequence the DNA of the novel coronavirus, once it was recognized as a unique infectious agent. That accelerated development of the vaccines.
Second was the global lockdown of ordinary citizens, accompanied by the ban on all public gatherings—be it sports, church services, concerts, or plays. Students did not go to school and parents worked from home. Cruise ships stayed in port, and the airlines carried just 25% of passengers per day compared to pre-pandemic levels.
Now, the latest stats on the Omicron variant indicate the pandemic may be winding down. On Jan. 24, 2022, the federal Centers for Disease Control and Prevention reported 1,025,249 new COVID-19 cases that day. As of Mar. 10, just 42,566 new COVID-19 cases were reported for that day.
These facts confront lab administrators and pathologists with the need to answer an important question: What happens to healthcare and the clinical laboratory industry as we move forward? Will the COVID-19 pandemic prove to be the fork in the road that propelled U.S. healthcare down a path that differed from what was laid out at the end of 2019?
Answer that question incorrectly and your laboratory organization may find itself moving in the wrong direction in coming years, with the consequence of lost clients and the inability to generate sufficient revenue to sustain operations. Answer the question correctly and the future could be clinically and financially robust for your laboratory, as well as for the hospitals, physicians, and payers and patients it serves.
As we’ve done for 27 years, your team at The Dark Report has been at work gathering experts who will share useful insights and knowledge about what’s coming next for healthcare and the House of Laboratory Medicine. When the Executive War College on Laboratory and Pathology Management convenes on April 27-28, 2022, in New Orleans, there will be 125 speakers and 75 sessions to help you understand what’s coming and how to position your lab to prosper. You should reserve your place today and bring your brightest management minds to this critical strategic gathering!
Comments
Volume XXIX, No. 4 – March 14, 2022
TABLE OF CONTENTS
COMMENTARY & OPINION BY R. LEWIS DARK
ARTICLES
INTELLIGENCE
Need A Group Membership? Company Discounts are Available!